The Sahin-Toth Laboratory focuses on hereditary chronic pancreatitis, a major risk factor for pancreatic cancer. Working in collaboration with the Dr. Guido Eibl’s The Ronald S. Hirshberg Translational Pancreatic Cancer […]
Understanding Early Tumor Progression Through Tuft Cells
One of the main ways to improve the outcomes for pancreatic cancer patients is early diagnosis and the way to better diagnostics is through a greater understanding of the initiating […]
Our UCLA Activity Summary Report is now Available
The Hirshberg Foundation maintains its longstanding partnership with UCLA and is a crucial source of support for a wide range of research programs, patient care initiatives, and faculty members in […]
UCLA Researchers Receive Over $6M from NIH to Study Potential Immunotherapies for Pancreatic Cancer
Research teams at UCLA have received two grants from the National Institutes of Health (NIH), totaling over $6 million dollars to study the immunobiology of pancreatic tumors and develop a […]
Hirshberg funded UCLA study finds combination therapy suppresses pancreatic tumor growth
UCLA Jonsson Comprehensive Cancer Center researchers, including our Scientific Advisory Board member and close collaborator, Dr. Timothy Donahue have uncovered a therapy that subdues tumor growth. The study, published in […]
Research Publications from the Sahin-Toth Laboratory in 2020
In 2019 the Hirshberg Foundation supported UCLA in the recruitment of Miklos Sahin-Toth, MD, PhD, a leading pancreatic disease researcher and a specialist in chronic pancreatitis. The Sahin-Toth Laboratory is […]